INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 5 analysts with an average price target of $18.7. This is a potential upside of $13.08 (232.74%) from yesterday's end of day stock price of $5.62.

Inovio Pharmaceuticals's activity chart (see below) currently has 101 price targets and 104 ratings on display. The stock rating distribution of INO is 87.5% HOLD and 12.5% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.18% with an average time for these price targets to be met of 549.29 days.

Highest price target for INO is $15, Lowest price target is $4, average price target is $18.7.

Most recent stock forecast was given by GREGORY RENZA from RBC on 04-Oct-2024. First documented stock forecast 18-Jun-2014.

Currently out of the existing stock ratings of INO, 7 are a HOLD (87.5%), 1 are a BUY (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$7

$1.55 (28.44%)

$8

1 months 1 days ago
(04-Oct-2024)

13/17 (76.47%)

$1.45 (26.13%)

417

Hold

$15

$9.55 (175.23%)

3 months 21 days ago
(15-Jul-2024)

4/5 (80%)

$3.94 (35.62%)

914

Buy

$4

$-1.45 (-26.61%)

9 months 11 days ago
(25-Jan-2024)

1/2 (50%)

$-2.79 (-41.09%)

433

Hold

$4.8

$-0.65 (-11.93%)

11 months 26 days ago
(10-Nov-2023)

1/1 (100%)

$0.61 (14.56%)

6

Hold

$240

1 years 11 months 27 days ago
(09-Nov-2022)

7/8 (87.5%)

$94.32 (64.74%)

713

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 549.29 days on average for the stock forecasts to be realized with a an average price target met ratio 84.18

Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 11 price targets and 8 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Thomas Shrader with highest potential upside - $126.55

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Hartaj Singh with lowest potential downside - -$1.45

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?